akhatri

/akhatri

About akhatri

This author has not yet filled in any details.
So far akhatri has created 9 blog entries.

Guidance on handling ‘FS’ endorsed prescriptions for free supply of sexual health treatments

As ‘FS’ endorsed prescription items become more common, Community Pharmacy England has released updated guidance on how pharmacies should handle these prescriptions. Community pharmacies are seeing an increase in electronic prescriptions with items endorsed ‘FS’ for free supply of sexual health treatment. This increase has been partially driven by the adoption of EPS by sexual [...]

The post Guidance on handling ‘FS’ endorsed prescriptions for free supply of sexual health treatments appeared first on Community Pharmacy England.

By |November 20th, 2024|Lexpos News|Comments Off on Guidance on handling ‘FS’ endorsed prescriptions for free supply of sexual health treatments

Expiry of SSP076 Nyzamac® SR 60mg capsules

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Nyzamac® SR 60mg capsules is now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP076 Nyzamac® SR 60mg capsules expires at 23.59pm on Friday 8 November 2024. After this date, any prescriptions for Nyzamac® SR 60mg [...]

The post Expiry of SSP076 Nyzamac® SR 60mg capsules appeared first on Community Pharmacy England.

By |November 8th, 2024|Lexpos News|Comments Off on Expiry of SSP076 Nyzamac® SR 60mg capsules

MHRA Class 4 Medicines Defect Information: Zoledronic Acid Ennogen 4mg/5ml concentrate for solution for infusion (Ennogen Healthcare Limited)

Class 4 Medicines Defect Information: Zoledronic Acid Ennogen 4mg/5ml concentrate for solution for infusion (Ennogen Healthcare Limited) Drug alert number: EL (24)A/53 Date issued: 07 November 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Zoledronic Acid Ennogen 4mg/5ml concentrate for solution for infusion (Ennogen [...]

The post MHRA Class 4 Medicines Defect Information: Zoledronic Acid Ennogen 4mg/5ml concentrate for solution for infusion (Ennogen Healthcare Limited) appeared first on Community Pharmacy England.

By |November 7th, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Zoledronic Acid Ennogen 4mg/5ml concentrate for solution for infusion (Ennogen Healthcare Limited)

MHRA Drug Safety Update: November 2024

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 18 Issue 4 November 2024) has been published and includes articles on: MedSafetyWeek November 2024: your Yellow Card report helps prevent future harm to others and improves patient safety Letters and medicine recalls sent to healthcare professionals in October 2024 To see the [...]

The post MHRA Drug Safety Update: November 2024 appeared first on Community Pharmacy England.

By |November 6th, 2024|Lexpos News|Comments Off on MHRA Drug Safety Update: November 2024

NHSBSA Online Webinars for Pharmacy Teams

The NHS Business Services Authority (NHSBSA) host webinars to provide an insight into how they process and reimburse prescriptions. These sessions take place online and last approximately 60 minutes. During the sessions, pharmacy teams are shown how NHSBSA handle prescription submissions and are given an overview of the most common errors found on prescriptions submitted [...]

The post NHSBSA Online Webinars for Pharmacy Teams appeared first on Community Pharmacy England.

By |November 1st, 2024|Lexpos News|Comments Off on NHSBSA Online Webinars for Pharmacy Teams